Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Change in Account Payables (2016 - 2025)

Mesa Laboratories' Change in Account Payables history spans 16 years, with the latest figure at $124000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 107.17% year-over-year to $124000.0; the TTM value through Dec 2025 reached $658000.0, up 282.78%, while the annual FY2025 figure was -$388000.0, 300.0% down from the prior year.
  • Change in Account Payables for Q4 2025 was $124000.0 at Mesa Laboratories, up from -$1.2 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.6 million in Q1 2024 and bottomed at -$1.7 million in Q4 2024.
  • The 5-year median for Change in Account Payables is -$52500.0 (2022), against an average of -$31850.0.
  • The largest annual shift saw Change in Account Payables skyrocketed 856.8% in 2024 before it crashed 707.54% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $1.4 million in 2021, then tumbled by 210.09% to -$1.6 million in 2022, then soared by 77.94% to -$349000.0 in 2023, then crashed by 395.7% to -$1.7 million in 2024, then soared by 107.17% to $124000.0 in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Change in Account Payables are $124000.0 (Q4 2025), -$1.2 million (Q3 2025), and $212000.0 (Q2 2025).